search
Back to results

Efficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in Children (DEXPED)

Primary Purpose

IV Drug Usage

Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Dexamethasone
Placebos
Sponsored by
Central Hospital, Nancy, France
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for IV Drug Usage focused on measuring dexamethasone, analgesia, lower limb blockade, children, pediatric

Eligibility Criteria

6 Years - 15 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia with an anesthesic consultation between 90 to 2 days before the surgery
  • Legal guardian agreement
  • Children who are affiliated to the social security
  • Information of minor subjects adapted to their ability to understand

Exclusion Criteria:

  • Children who presents a contraindication to the single shot IV dexamethasone
  • Septic surgery
  • Diabetes
  • Corticoid treatment in the 7 days before the surgery - outpatient surgery
  • Handicapped or impaired children
  • Pregnant patient
  • Peri-nerval catheter
  • Children who are privated from their liberty because of a court or administrative decision or need psychiatric care
  • Uncontrolled psychotic state
  • Pregnant patients

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    dexamethasone

    Placebos

    Arm Description

    IV dexamethasone group : dexamethasone administrated at the induction of general anesthesia, at the dose of 0,2mg/kg (= 0,2mL/kg of a syringe with a 1mg/mL concentration) maximum 8mg (=8mL).

    IV placebo group : saline serum is administrated at the induction of general anesthesia, at the dose of 0,2mL/kg, maximum 8mL.

    Outcomes

    Primary Outcome Measures

    Morphinic consumption in the post operative 24H
    total morphinic consumption in morphine equivalent in mg

    Secondary Outcome Measures

    Delay between the realisation of the lower limb blockade ans the first - consumption of morphinic
    delay in minutes between the realization of the lower limb blockade and the first consumption of morphinic
    Duration the the motor blockade
    motor blockade evaluated with the bromide score over 6 points, duration to recover a score of 6/6 (no more blockade) in minutes
    Prevalence of post opérative nausea/vomiting
    evaluated with no nausea/vomiting, nausea OR vomiting, nausea AND vomiting

    Full Information

    First Posted
    August 1, 2018
    Last Updated
    August 1, 2018
    Sponsor
    Central Hospital, Nancy, France
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03618173
    Brief Title
    Efficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in Children
    Acronym
    DEXPED
    Official Title
    Efficiency of IV Dexamethasone Compared to Placebo, Administrated After a Lower Limb Blockade is Done, on the Post Operative Pain in Children : a Controled, Randomised, Double Blind Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 1, 2018 (Anticipated)
    Primary Completion Date
    September 1, 2020 (Anticipated)
    Study Completion Date
    September 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Central Hospital, Nancy, France

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Intravenous dexamethasone (IV) can be used alone in adults as an adjunct to peri-nerves blocks, for diffusion blocks. In pediatrics, dexamethasone is used daily according to the assessment of the anesthetist, by extension of the recommendations of the adult, as adjuvant in perinervous blocks although no study has been published yet concerning his interest. However, the physiology of the child is not superimposable to that of the adult (renal function, volume of distribution, plasma protein binding ...). We thus wish to study the effectiveness of the administration of IV dexamethasone at the time of anesthetic induction in the prolongation of the duration of the block of the lower limbs in the child and its repercussion on the postoperative consumption of morphine. Main Objective : Evaluate the efficiency, compared to placebo, of IV dexamethasone at the dose of 0.2 mg / kg administered as a bolus at the time of anesthetic induction, on the early postoperative pain (first 24 hours) in the child of 6 to 15 years undergoing surgery that requires the achievement of a peri-neural block of the lower limb after general anesthesia Secondary objectives : Evaluate the efficiency of 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, on the increase of the delay of first post operative morphinic consumption in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia. Evaluate that 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, doesn't increase the lower limb motor blokade duration in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia Evaluate the efficiency of 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, on the decrease of post operative nausea and vomiting in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia Principal endpoint : -Morphinic consumption in the post operative 24H Secondary endpoints : delay between the realisation of the lower limb blockade ans the first - consumption of morphinic duration the the motor blockade prevalence of post opérative nausea/vomiting
    Detailed Description
    Time 1: Pre-anesthetic consultation Recruitment is performed during the pre-anesthetic consultation, between D-90 and D-2 of the date of operation. The eligibility criteria will be checked and if the child is eligible to participate in the study, oral and written information about the study is given to the child's parents (or, failing that, to their legal representatives) by the anesthetist doctor. Minors will receive information adapted to their ability to understand. It can not be overridden by the refusal of the child or the revocation of his acceptance. The investigator will give the parents the consent form The parents then have a minimum of 48 hours to decide whether to participate in the study of their child. In all cases, an anesthesiologist doctor will be reachable (through the secretariat) at any time in case of additional questions during the reflection period. Time n ° 2: Pre-anesthetic visit If the parents and the child agree to participate in this study and after a new eligibility check, the consent signed by both parents will be collected the day before the intervention during the pre-anesthetic visit. The randomization will then be carried out and two groups will be created: A first group receiving 0.2 mg / kg of IV dexamethasone at the time of anesthetic induction A second group receiving the same volume of placebo (physiological saline) The anesthetist will send to the pharmacy, on a prescription, the results of the randomization (assignment code) the day before the procedure. The drugs in the study will be prepared by the pharmacy department of the University Hospital of Nancy at most 21 days in advance of the intervention. Indeed, a syringe for each randomization list (stratification on algebra level) will always be planned in advance and ready to be used for inclusion early in the morning (between 7:30 and 9:30). The packaging will be identical to guarantee the double blind. The pharmacy will send the drug to the operating room on the morning of the operation via a specific drug transport. On the morning of the operation, all patients included will receive a premedication with midazolam 0.3mg / kg per os 30 minutes max 10mg before surgery. The patient is then asleep (general anesthesia) according to the protocols in force (initial induction by inhaled sevoflurane and then peripheral venous route (VVP) and injection of sufentanil 0.1 gamma / kg and propofol 2-3mg / kg or VVP pose then IV anesthesia directly in the larger ones). Then a block of the lower limb with 0.3mL / kg of ropivacaine at the concentration of 2mg / mL, ultrasound guided with or without neurostimulation is performed. The patient then receives according to his group: either 0.2 mg / kg of IV dexamethasone at the time of anesthetic induction or the same volume of placebo (physiological saline) at the time of anesthetic induction. Maintenance of general anesthesia is done by sevoflurane with sufentanil reinjection at the discretion of the anesthesiologist. In the intraoperative period, the patient will receive a systematic injection of paracetamol 15mg / kg IVL 30 minutes before the end of the surgical procedure. Once the operation is complete, the patient is transferred to the post-interventional surveillance room with awakening and evaluation of the pain (by EVA scale) and postoperative nausea (by questioning the child), noting the hours of statement. The existence of a motor block of the operated lower limb is also evaluated and recorded. Thereafter, the patient returns to conventional service with regular evaluation (every 4 hours) of pain and nausea / vomiting (every 4 hours). The pain intensity will be evaluated by a scale validated from the age of 6: evaluation by analogue verbal scale (EVA) giving a painful intensity over 100: 100/100 being the maximum intensity imaginable, 0/100 the absence of pain. The occurrence of postoperative nausea and vomiting will be assessed as follows: no nausea / vomiting, nausea without vomiting, nausea and vomiting. If the EVA is greater than 30 in the 24 hours postoperative: an injection of Nalbuphine 0.2mg / kg IVL or morphine 0.1mg / kg max 3mg every 4 to 6 hours will be performed; in the event of failure (persistence of an EVA> 30 to 30 mins), a new dose of paracetamol 15mg / kg may be administered again 6 hours after the first dose injected intraoperatively. In the event of nausea and / or postoperative vomiting, ondansetron 0.1mg / kg every 8h will be administered and then in case of failure at 30 minutes, droperidol 10 microgram / kg every 8h.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    IV Drug Usage
    Keywords
    dexamethasone, analgesia, lower limb blockade, children, pediatric

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    80 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    dexamethasone
    Arm Type
    Experimental
    Arm Description
    IV dexamethasone group : dexamethasone administrated at the induction of general anesthesia, at the dose of 0,2mg/kg (= 0,2mL/kg of a syringe with a 1mg/mL concentration) maximum 8mg (=8mL).
    Arm Title
    Placebos
    Arm Type
    Placebo Comparator
    Arm Description
    IV placebo group : saline serum is administrated at the induction of general anesthesia, at the dose of 0,2mL/kg, maximum 8mL.
    Intervention Type
    Drug
    Intervention Name(s)
    Dexamethasone
    Other Intervention Name(s)
    IV dexamethasone
    Intervention Description
    IV dexamethasone at the dose of 0,2mg/kg = 0,2mL/kg of a solution of 1mg/mL max 8mg
    Intervention Type
    Drug
    Intervention Name(s)
    Placebos
    Other Intervention Name(s)
    IV saline serum
    Intervention Description
    IV saline serum at the dose of 0,2mL/kg maximum 8mL
    Primary Outcome Measure Information:
    Title
    Morphinic consumption in the post operative 24H
    Description
    total morphinic consumption in morphine equivalent in mg
    Time Frame
    within 24 hours after dexamethasone or saline serum administration
    Secondary Outcome Measure Information:
    Title
    Delay between the realisation of the lower limb blockade ans the first - consumption of morphinic
    Description
    delay in minutes between the realization of the lower limb blockade and the first consumption of morphinic
    Time Frame
    within 24 hours after dexamethasone or saline serum administration
    Title
    Duration the the motor blockade
    Description
    motor blockade evaluated with the bromide score over 6 points, duration to recover a score of 6/6 (no more blockade) in minutes
    Time Frame
    within 24 hours after dexamethasone or saline serum administration
    Title
    Prevalence of post opérative nausea/vomiting
    Description
    evaluated with no nausea/vomiting, nausea OR vomiting, nausea AND vomiting
    Time Frame
    within 24 hours after dexamethasone or saline serum administration

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Years
    Maximum Age & Unit of Time
    15 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia with an anesthesic consultation between 90 to 2 days before the surgery Legal guardian agreement Children who are affiliated to the social security Information of minor subjects adapted to their ability to understand Exclusion Criteria: Children who presents a contraindication to the single shot IV dexamethasone Septic surgery Diabetes Corticoid treatment in the 7 days before the surgery - outpatient surgery Handicapped or impaired children Pregnant patient Peri-nerval catheter Children who are privated from their liberty because of a court or administrative decision or need psychiatric care Uncontrolled psychotic state Pregnant patients
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Nicolas VAUTRIN
    Phone
    0676430560
    Email
    nicolas_vautrin@hotmail.fr
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Claude Meistelman
    Organizational Affiliation
    University Professor in CHRU Nancy
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    32998920
    Citation
    Vautrin N, Thilly N, Bernard Y, Wurtz F, Meistelman C. Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial. BMJ Open. 2020 Sep 30;10(9):e036863. doi: 10.1136/bmjopen-2020-036863.
    Results Reference
    derived

    Learn more about this trial

    Efficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in Children

    We'll reach out to this number within 24 hrs